Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • CACA GU | Professor Zhuowei Liu: Advancing Standardized Urologic Oncology Care from Prevention to Comprehensive Management

    Approximately 101,000 new cases of bladder cancer are diagnosed annually in China, making it the 11th most common malignancy. The disease is more prevalent in southern China than in the north, and its incidence is trending toward younger age groups. Meanwhile, high-risk localized or locally advanced prostate cancer carries a substantial risk of biochemical recurrence…

    2026.09.28
  • CSCO 2026 | Professor Xinan Sheng: Clinical Insights from 3.5-Year Follow-Up of the EV-302 Trial—Long-Term Survival Benefits and Treatment Continuity

    Platinum-based chemotherapy has historically been the standard first-line treatment for locally advanced or metastatic urothelial carcinoma (la/mUC), but long-term survival outcomes have remained poor. There is an urgent clinical need for first-line regimens that offer high efficacy and sustained disease control. The EV-302 trial directly compared enfortumab vedotin plus pembrolizumab with standard platinum-based chemotherapy. Earlier…

    2026.09.28
  • 2026 Cross-Strait Hematology Academic Conference | Huiju Tsai: Empowering Transplant Care with the TBMT APP and Advancing Nursing Development Through Cross-Strait Collaboration

    In the golden autumn season, experts from across the Taiwan Strait gathered in Zhuhai. The 2026 Cross-Strait Hematology Academic Conference was held in Zhuhai, Guangdong, on August 21–22, bringing together hematology experts and scholars from both sides of the Taiwan Strait, as well as Hong Kong and Macao, for in-depth discussions on cutting-edge developments, clinical…

    2026.09.16
  • 2026 Cross-Strait Hematology Academic Conference | Dr. Sheng‑Hsuan Chien: From Taiwan’s Experience to Precision Transfusion—Exploring the Path Forward for Patient Blood Management (PBM)

    Transfusion medicine is an essential foundation for the diagnosis and treatment of hematologic diseases, and its underlying philosophy is undergoing a profound transformation from a “blood-centered” to a “patient-centered” approach. As the field advances standardized blood utilization and transfusion safety, how to establish a scientific blood management system and implement precision transfusion strategies remains a…

    2026.09.16
  • Gaobo Medical Forum 2026 | Professor Dehui Zou: Precision Positioning and Optimization Strategies for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma in the Era of Novel Therapies

    The “Gaobo Medical Forum—6th Shanghai Clinical Application Seminar on Hematopoietic Stem Cell Transplantation and Training Course on the Clinical Application of Autologous Hematopoietic Stem Cell Transplantation,” hosted by the National Clinical Research Center for Hematologic Diseases of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, and organized by Shanghai Zhaxin…

    2026.09.16
  • Gaobo Medical Forum 2026 | Dr. Su Li: A Comprehensive Analysis of BCMA/GPRC5D Dual-Target CAR-T Therapy in RRMM—Mechanisms, Efficacy, and Combination Strategies

    The “Gaobo Medical Forum—6th Clinical Application Seminar and Training Course on Autologous Hematopoietic Stem Cell Transplantation,” hosted by the National Clinical Research Center for Hematologic Diseases of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, and organized by Shanghai Zhaxin Hospital/Gaobo Medical Group and Shanghai Liquan Hospital, was held in…

    2026.09.16
  • CSCO 2026 Outlook | Professor Jun Ma: Hematologic Malignancies Continue to Lead Innovation, Advancing Oncology Toward Long-Term Survival

    The 2026 Chinese Society of Clinical Oncology (CSCO) Annual Meeting will be held in Jinan, Shandong, from September 16 to 19, 2026. As one of China’s most important annual academic events in oncology, the CSCO Annual Meeting continues to focus on the international frontiers of oncology research and the needs of clinical practice in China.…

    2026.09.16
  • Professor Jun Zhu: Precision Strategies in Hematopoietic Stem Cell Transplantation — From the Clinical Positioning of Autologous Transplantation to Comprehensive Management of HLH丨Gaobo Medical Forum 2026

    On August 29–30, 2026, the “Gaobo Medical Forum — 6th Symposium on the Clinical Application of Autologous Hematopoietic Stem Cell Transplantation and Training Course on the Clinical Application of Autologous Hematopoietic Stem Cell Transplantation,” hosted by the National Clinical Research Center for Blood System Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of…

    2026.09.14
«previous next»
Recent Posts
  • 2026 CSCO China–International Dialogue | Professor Kai-Keen Shiu analyzes breakthrough strategies for immunotherapy in MSS/pMMR colorectal cancer
  • Professor Aibin Liang: Enhancing CAR-T Therapy with the A2AR-Targeting Natural Product TAIII—From CAR-Treg Mechanisms to Clinical Translation | 2026 China-France Scientific Symposium on Hematology and Immunology
  • China and France Join Forces to Advance Hematology and Immunology: The 2026 China-France Scientific Symposium on Hematology and Immunology Held in Beijing
  • Professor Suning Chen: Standardized Diagnosis and Treatment of Acute Myeloid Leukemia in Young Adults | 2026 China-France Scientific Symposium on Hematology and Immunology
  • CSCO 2026 | Professor Aijun Liu: Phase II Study of Eprenetapopt Combined With Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top